Page last updated: 2024-09-03

cgp 28392 and san 202791

cgp 28392 has been researched along with san 202791 in 2 studies

Compound Research Comparison

Studies
(cgp 28392)
Trials
(cgp 28392)
Recent Studies (post-2010)
(cgp 28392)
Studies
(san 202791)
Trials
(san 202791)
Recent Studies (post-2010) (san 202791)
76123102

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Halushka, PV; Mais, DE; Mayeux, PR1
Dannies, PS; Law, GJ; Pachter, JA1

Other Studies

2 other study(ies) available for cgp 28392 and san 202791

ArticleYear
Interactions of dihydropyridine Ca2+ channel agonists with the human platelet thromboxane A2/prostaglandin H2 receptor.
    European journal of pharmacology, 1991, Jan-25, Volume: 206, Issue:1

    Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Affinity Labels; Blood Platelets; Calcium Channel Agonists; Calcium Channel Blockers; Dihydropyridines; Fura-2; Humans; In Vitro Techniques; Iodine Radioisotopes; Kinetics; Manganese; Prostaglandin Endoperoxides, Synthetic; Prostaglandin H2; Prostaglandins H; Pyridines; Radioligand Assay; Receptors, Prostaglandin; Receptors, Thromboxane; Stereoisomerism

1991
Ca2+ channel agonists enhance thyrotropin-releasing hormone-induced inositol phosphates and prolactin secretion.
    European journal of pharmacology, 1991, Apr-03, Volume: 195, Issue:3

    Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Radioisotopes; Dihydropyridines; Female; In Vitro Techniques; Inositol Phosphates; Nimodipine; Perfusion; Prolactin; Pyridines; Rats; Rats, Inbred Strains; Receptors, Purinergic; Thyrotropin-Releasing Hormone

1991